import { BlogDPP4VsGLP1 } from "../../../components/blog-dpp4-vs-glp-1-incretin-system.jsx";

export const metadata = {
  robots: { index: true, follow: true },
  alternates: {
    canonical: 'https://telehealthfx.com/blog/dpp4-vs-glp-1-incretin-system/',
  },
  title: "DPP-4 Inhibitors vs. GLP-1 Agonists: Understanding the Incretin System (2026 Guide)",
  description: "DPP-4 inhibitors vs GLP-1 agonists explained. How Januvia differs from Ozempic at the molecular level, why GLP-1 agonists produce superior weight loss and cardiovascular benefits.",
  openGraph: {
    title: "DPP-4 Inhibitors vs. GLP-1 Agonists: The Incretin System Explained",
    description: "How Januvia differs from Ozempic at the molecular level and why GLP-1 agonists dominate metabolic medicine.",
    images: [{ url: "https://telehealthfx.com/assets/dpp4-vs-glp1-featured.png", width: 1200, height: 630, alt: "DPP-4 vs GLP-1" }],
  },
};

export default function Page() {
  const jsonLd = { "@context": "https://schema.org", "@graph": [
    { "@type": "MedicalWebPage", "@id": "https://telehealthfx.com/blog/dpp4-vs-glp-1-incretin-system/#article", "headline": "DPP-4 Inhibitors vs. GLP-1 Agonists: Understanding the Incretin System", "image": "https://telehealthfx.com/assets/dpp4-vs-glp1-featured.png", "author": { "@type": "Person", "name": "Julian Mercer, M.S.", "url": "https://telehealthfx.com/about" }, "publisher": { "@type": "Organization", "name": "Telehealth FX" }, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://telehealthfx.com/blog/dpp4-vs-glp-1-incretin-system/" } },
    { "@type": "FAQPage", "@id": "https://telehealthfx.com/blog/dpp4-vs-glp-1-incretin-system/#faq", "mainEntity": [
      { "@type": "Question", "name": "Can I take a DPP-4 inhibitor and GLP-1 agonist together?", "acceptedAnswer": { "@type": "Answer", "text": "No. They target the same pathway. The GLP-1 agonist makes the DPP-4 inhibitor redundant." } },
      { "@type": "Question", "name": "Why doesn't Januvia cause weight loss like Ozempic?", "acceptedAnswer": { "@type": "Answer", "text": "DPP-4 inhibitors achieve only 2–3x native GLP-1 levels, far below the 10–100x threshold needed for appetite suppression." } }
    ]}
  ]};
  return (<><script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(jsonLd) }} /><BlogDPP4VsGLP1 /></>);
}
